Nijmegen, Gelderland, Netherlands
Jan Smeitink
2012
50
Private company
3.3
Mitochondrial dysfunction
MELAS, Leigh syndrome
small molecule drugs
Khondrion is a clinical-stage biopharmaceutical company discovering and developing therapies targeting mitochondrial disease. The company is advancing its proprietary science through a wholly-owned clinical and preclinical small molecule pipeline of potential medicines.